Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1glp-1obesitytreatment duration

Medscape asks whether GLP-1 obesity treatment must continue indefinitely

Clinical feature examines long-term and lifelong use questions for GLP-1 drugs in obesity management.

MH
By Maren Holt · Senior Reporter, GLP-1
Sep 15 04:24 ETSource: Medscape

The wire

  1. 01Medscape published an analysis of whether obesity treatment with GLP-1 drugs should be lifelong.
  2. 02Duration of therapy affects cost, adherence and weight regain after discontinuation.
  3. 03The piece is a clinical discussion; no new trial data or guideline change is reported.

From the source

Can Obesity Treatment With GLP-1 Drugs Last Forever?

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMinAFBVV95cUxPNHVVeEhOQkVLZkNFUk9vSVlMdVE5Smp4WjZjQl9iRl93TnRQWHBvMkV6aVIyZFp2STdLZ05BM1FyWU54REdNa0tsc3I5WE82ZUtzVHhVYndrX3VqYTUwbUR3UGQxQVU0MHRhbHpERzhYdnd5SmxlTjlzbS1IYlJLeWU0a2Ryb0dvcmREblAxZzFZd3IzaFpxUkN0MEk?oc=5